Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 26256
IPSCIO Record ID: 173732
Unlike the traditional drug development process of identifying and synthesizing single bioactive molecules from plant sources, the Company's core technologies were developed based on empirical data that suggests that the health benefits and safe usage of certain plant-derived therapeutics might be the result of the natural combination of multiple molecules found in the plant extract and that single molecules, in isolation, may not replicate the natural plants' effectiveness. The PharmaPrint Process technology enables the Company to identify and quantify the bioactives within plant sources that are believed to provide therapeutic benefits and produce dietary supplements and pharmaceuticals having consistent batch-to-batch quantities and ratios of these bioactives.
IPSCIO Record ID: 28225
Pharmaceutical Grade Botanical Drugs 04/15/97 28131/97 Issued
Pharmaceutical Grade Echinacea 10/23/98 13634/99 Pending
Pharmaceutical Grade Ginkgo Biloba 10/23/98 13633/99 Pending
Pharmaceutical Grade Ginseng 10/23/98 11183/99 Pending
Pharmaceutical Grade Saw Palmetto, 10/23/98 13635/99 Pending
Pharmaceutical Grade St. John's Wort 10/23/98 13631/99 Pending
Pharmaceutical Grade Valerian, Black 10/23/98 13632/99 Pending
Cohosh, Vitex Agnus-Castus, Bilberry and Milk Thistle
IPSCIO Record ID: 9475
Licensor hereby grants to Licensee a non-exclusive right, without the right to grant sublicenses except to Licensee's Affiliate(s), under the Patent Rights to use the Herbal Products, including the Licensed Products, in the OTC Market in the Territory.
The Trademark shall mean the trademark PHARMAPRINT.
Herbal Product shall mean a dietary supplement derived from botanical herbal extracts.This agreement is for the dietary supplement industry.
The term 'Process Patent' shall mean U.S. Patent Application No. 08/838,199, filed April 15, 1997, a continuation-in-part application of U.S. Patent Application No. 08/632,273, filed April 15, 1996 or a patent issued on a divisional, continuation or continuation-in-part application on one or more of the patent applications for the Process Patent.